Macrilen

Chemical Namemacimorelin acetate
Dosage FormSuspension (oral; 60 mg)
Drug ClassReceptor agonists
SystemEndocrine
CompanyNovo Nordisk
Approval Year2017

Indication

  • Indicated for the diagnosis of adult growth hormone deficiency.
Last updated on 9/9/2022

More on this drug: Clinical Trials

Document TitleYearSource
Macrilen (macimorelin acetate) Prescribing Information.2021Novo Nordisk Inc., Plainsboro, NJ
Document TitleYearSource
Macimorelin as a diagnostic test for adult GH deficiency.2018The Journal of Clinical Endocrinology & Metabolism

Have we missed a study, or would you like to comment on a study?